Selective Inhibitors of Arginine Methyl Transferase 5 (PRMT5) As a Novel Treatment for β-Thalassemia and Sickle Cell Disease von Street, Ian, Monahan, Brendon, Falk, Hendrik, Allan, Elizabeth, Bergman, Ylva, Stupple, Paul, Holmes, Ian, Gregg, Alison, Charman, Susan, Lackovic, Kurt, Peat, Tom, Walker, Scott, Lowes, Kym, Kersten, Wilco, Alcindor, Jo, Chung, Matthew, Parker, Michael, Foitzik, Richard, Camerino, Michelle, Nikac, Marcia, Grusovin, Julian, Pilling, Pat, Sonderegger, Stefan, Tan, Yuen, Zhao, Quan, Curtis, David J., Jane, Stephen M

Volltext

Randomised Phase 3 Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE II von Chua, Yu Jo, Pavlakis, Nick, Sjoquist, Katrin M., Martin, Andrew J., Tsobanis, Eric, Yip, Sonia, Bang, Yung-Jue, Alcindor, Thierry, O’callaghan, Christopher J., Bekaii-Saab, Tanios S., Grothey, Axel, Chen, Li-Tzong, Simes, John, Zalcberg, John R., Goldstein, David, Komatsu, Yoshito, Machida, Nozomu, Esaki, Taito, Hara, Hiroki, Shitara, Kohei

Volltext

P2-228 [Encore]Randomised Phase 3 Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE II von Chua, Yu Jo, Pavlakis, Nick, Sjoquist, Katrin M, Martin, Andrew J, Tsobanis, Eric, Yip, Sonia, Bang, Yung-Jue, Alcindor, Thierry, O’callaghan, Christopher J, Bekaii-Saab, Tanios S, Grothey, Axel, Chen, Li-Tzong, Simes, John, Zalcberg, John R, Goldstein, David, Komatsu, Yoshito, Machida, Nozomu, Esaki, Taito, Hara, Hiroki, Shitara, Kohei

Volltext